Patent · US Active

Infective countermeasures

US12003614B2 · kind B2 · utility

0Cited by
2References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 26, 2022
Grant dateJun 4, 2024
Priority date
Expiry dateNov 25, 2042

Classification

  • Technology area (CPC H)Electricity
  • CPC primaryH04L2209/12
  • WIPO fieldDigital communication
  • WIPO sectorElectrical engineering

Abstract

The invention proposes a novel type of infective countermeasure against fault injection attacks. Instead of determining the injected error before amplifying it, the novel countermeasure applies the same diffusion function to two intermediate ciphers obtained by executing a cryptographic operation on an input. The error is therefore amplified within the same intermediate ciphers, referred to as infective ciphers after diffusion. It is then possible to use diffusion functions which do not map the cipher 0 as an output equal to 0. A cipher recomposed from bits of undiffused ciphers is also generated. These infective and recomposed ciphers are XOR-combined to provide an output cipher. This approach makes it possible to adapt, by simple duplication of the pairs and associated specific diffusion functions, the protection offered by the countermeasure to a desired number of injected faults.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.